δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8+ T cell activation

δ-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8+ T cell activation

As classical therapy method of advanced hepatocellular carcinoma (HCC) is not effective enough, HCC immunotherapy is a hot spot for research in recent years. Although in recent years, immune checkpoint inhibitors are focused in cancer therapy, vaccines and adoptive cell therapy (ACT), as traditional...

Full description

Bibliographic Details
Main Authors: Fei Huang, Junying Chen, Ruilong Lan, Zeng Wang, Ruiqing Chen, Jingan Lin, Lurong Zhang, Lengxi Fu
Format: Article
Language:English
Published: Taylor & Francis Group 2018-08-01
Series:OncoImmunology
Subjects:
ctl
erk signaling
hepatocellular carcinoma
peptide vaccines
δ-catenin
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1450713

Internet

http://dx.doi.org/10.1080/2162402X.2018.1450713

Similar Items